Swiss drug major Novartis' Indian arm is upbeat about its rural sales initiative, Arogya Parviar and plans to double its reach in the country over the next few years. "Arogya Parivar that started......
The face of MNC drug firms in India and champion of IPR protection, he oversaw the Swiss giant's India expansion, its forays into new therapies and setting up of its global service centre in......
Novartis India Ltd has reported a 83.48 per cent rise in net profit at Rs 113.76 crore (Rs 1,137.6 million) for the fiscal ended March 31, 2004, compared to Rs 62 crore (Rs 620 million) in the......
The government should take measures to promote innovation and R&D while simplifying regulations for the sector in the upcoming Union Budget, as per pharmaceutical industry bodies. Illustration:......
Switzerland-based, Novartis AG, the parent company of Novartis India, is likely to revise its open offer price to buy back an additional stake of up to 39 per cent of equity to increase its......